Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck
$48,916R01FY2024CANIH
Emory University, Atlanta GA
Investigators
Linked publications, trials & patents
Abstract
PROJECT SUMMARY/ABSTRACT Not Requested
View original record on NIH RePORTER →